Akira Suda

1.0k total citations
46 papers, 723 citations indexed

About

Akira Suda is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Akira Suda has authored 46 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 10 papers in Clinical Psychology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Akira Suda's work include Heart Rate Variability and Autonomic Control (6 papers), HIV/AIDS drug development and treatment (5 papers) and Schizophrenia research and treatment (5 papers). Akira Suda is often cited by papers focused on Heart Rate Variability and Autonomic Control (6 papers), HIV/AIDS drug development and treatment (5 papers) and Schizophrenia research and treatment (5 papers). Akira Suda collaborates with scholars based in Japan, Sweden and Germany. Akira Suda's co-authors include Eleni Aklillu, Jürgen Burhenne, N. Ueda, Walter E. Haefeli, Yoshio Hirayasu, Getachew Aderaye, Getnet Yimer, Eyasu Makonnen, Abiy Habtewold and Lars Lindquist and has published in prestigious journals such as PLoS ONE, International Journal of Environmental Research and Public Health and Clinical Pharmacology & Therapeutics.

In The Last Decade

Akira Suda

43 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akira Suda Japan	14	234	199	120	116	113	46	723
N. Ueda Japan	13	228 1.0×	136 0.7×	91 0.8×	94 0.8×	89 0.8×	23	722
Neil Roskell United States	17	140 0.6×	62 0.3×	132 1.1×	67 0.6×	62 0.5×	31	913
Martine Monnat Switzerland	11	86 0.4×	230 1.2×	56 0.5×	107 0.9×	71 0.6×	23	697
Paolo Baroldi Italy	12	353 1.5×	101 0.5×	95 0.8×	108 0.9×	55 0.5×	23	733
Marcelo M. Gutierrez United States	13	102 0.4×	53 0.3×	205 1.7×	89 0.8×	65 0.6×	29	787
Dami A. Collier United Kingdom	11	217 0.9×	98 0.5×	308 2.6×	16 0.1×	69 0.6×	20	749
David Herion United States	15	177 0.8×	77 0.4×	73 0.6×	27 0.2×	965 8.5×	20	1.8k
H. Krüger Germany	15	63 0.3×	188 0.9×	100 0.8×	143 1.2×	143 1.3×	24	1.1k
Joan Albert Arnáiz Spain	14	170 0.7×	28 0.1×	58 0.5×	17 0.1×	72 0.6×	35	618
Zané Lombard South Africa	16	108 0.5×	132 0.7×	10 0.1×	62 0.5×	94 0.8×	43	765

Countries citing papers authored by Akira Suda

Since Specialization

Citations

This map shows the geographic impact of Akira Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Suda more than expected).

Fields of papers citing papers by Akira Suda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Suda. The network helps show where Akira Suda may publish in the future.

Co-authorship network of co-authors of Akira Suda

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Suda. A scholar is included among the top collaborators of Akira Suda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Suda. Akira Suda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujita, Junichi, et al.. (2025). Challenges in Implementing a Mobile AI Chatbot Intervention for Depression Among Youth on Psychiatric Waiting Lists: Randomized Controlled Study Termination Report. JMIRx Med. 6. e70960–e70960. 3 indexed citations

Taniguchi, Hayato, et al.. (2025). Elevated neutrophil-lymphocyte ratio as a biomarker for suicide attempts in emergency department physical trauma patients: a retrospective observational study. Journal of Psychiatric Research. 191. 30–38.

Nakata, Takashi, Daisuke Kudo, Yasushi Kudo, et al.. (2024). Effects of hybrid emergency department on extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest patients. Resuscitation Plus. 20. 100764–100764. 1 indexed citations

Suda, Akira, Kenji Okazaki, Junichi Fujita, et al.. (2024). Biological aging analysis based on DNA methylation status for social anxiety disorder. Neuropsychopharmacology Reports. 44(4). 774–783. 3 indexed citations

Chiba, Yuhei, et al.. (2024). Wheelchair dependence in patients with dementia: Focus on kinematic gait analysis using simple wearable accelerometers and gyroscopes. Assistive Technology. 36(6). 398–404. 1 indexed citations

Suda, Akira, Ikuko Kishida, Taku Furuno, et al.. (2023). Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia. BMC Psychiatry. 23(1). 135–135. 4 indexed citations

Asami, Takeshi, Akira Suda, Asuka Yoshimi, et al.. (2022). The psychological distress and suicide-related ideation in hospital workers during the COVID-19 pandemic: Second results from repeated cross-sectional surveys. PLoS ONE. 17(11). e0277174–e0277174. 5 indexed citations

Chiba, Yuhei, Kaori Ide, Asuka Yoshimi, et al.. (2022). Plasma MMP-9 Levels as the Future Risk of Conversion to Dementia in ApoE4-Positive MCI Patients: Investigation Based on the Alzheimer's Disease Neuroimaging Initiative Database. The Journal of Prevention of Alzheimer s Disease. 9(2). 331–337. 4 indexed citations

Chiba, Yuhei, et al.. (2021). A Severe Dementia Case in End of Life Care with Psychiatric Symptoms Treated by Perampanel. Journal of Epilepsy Research. 11(1). 93–95. 6 indexed citations

10.

Chiba, Yuhei, et al.. (2020). Influence of plasma cytokine levels on the conversion risk from MCI to dementia in the Alzheimer's disease neuroimaging initiative database. Journal of the Neurological Sciences. 414. 116829–116829. 7 indexed citations

11.

Suda, Akira, et al.. (2020). The association of genetic polymorphisms in CYP1A2, UGT1A4, and ABCB1 with autonomic nervous system dysfunction in schizophrenia patients treated with olanzapine. BMC Psychiatry. 20(1). 72–72. 12 indexed citations

12.

Chiba, Yuhei, Omi Katsuse, Yukitoshi Takahashi, et al.. (2020). Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis. Neuroscience Letters. 743. 135588–135588. 1 indexed citations

13.

Suda, Akira, Ikuko Kishida, Mami Fujibayashi, et al.. (2018). Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients. Neuropsychiatric Disease and Treatment. Volume 14. 2361–2366. 5 indexed citations

14.

Saito, Tomoyuki, Maasa Tamura, Yuhei Chiba, et al.. (2017). Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder. Journal of the Neurological Sciences. 379. 127–130. 14 indexed citations

15.

Kishida, Ikuko, Akira Suda, Mami Fujibayashi, et al.. (2017). Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia. Schizophrenia Research. 193. 134–138. 23 indexed citations

16.

Kishida, Ikuko, Akira Suda, Mami Fujibayashi, et al.. (2017). Long term effects of smoking cessation in hospitalized schizophrenia patients. BMC Psychiatry. 17(1). 87–87. 12 indexed citations

17.

Kishida, Ikuko, Akira Suda, Mami Fujibayashi, et al.. (2016). Association of the Cholinergic Muscarinic M2 Receptor with Autonomic Nervous System Activity in Patients with Schizophrenia on High-Dose Antipsychotics. Neuropsychobiology. 74(1). 60–67. 7 indexed citations

18.

Yimer, Getnet, Nobuhisa Ueda, Abiy Habtewold, et al.. (2011). Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients. PLoS ONE. 6(12). e27810–e27810. 84 indexed citations

19.

Yimer, Getnet, Wondwossen Amogne, Abiy Habtewold, et al.. (2011). High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study. The Pharmacogenomics Journal. 12(6). 499–506. 93 indexed citations

20.

Ngaimisi, Eliford, Sabina Mugusi, Omary Minzi, et al.. (2011). Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis. Clinical Pharmacology & Therapeutics. 90(3). 406–413. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact